Journal of Translational Medicine · 2019 · 17 citations · 6 references
ComputingHealth InformaticsInfectious DiseasesData MiningHealth Data AnalyticsMachine LearningComputer-aided DiagnosisInfectious Disease ScreeningPredictive Analytics For Population HealthPredictive Health ModelingViral HepatitisArtificial Intelligence-based ScreeningChronic Viral HepatitisHepatitis C InfectionHepatitis Virus DiagnosisInfection Risk PredictionMachine Learning For DiagnosisPrediction Model DevelopmentSelf-organizing Maps
BACKGROUND: Chronic hepatitis C virus (HCV)-infection is a slowly debilitating and potentially fatal disease with a high estimated number of undiagnosed cases. Given the major advances in the treatment, detection of unreported infections is a consequential step for eliminating hepatitis C on a population basis. The prevalence of chronic hepatitis C is, however, low in most countries making mass screening neither cost effective nor practicable. METHODS: We used a Kohonen artificial neural network (ANN) to analyze socio-medical data of 1.8 million insurants for predictors of undiagnosed HCV infections. The data had to be anonymized due to ethical requirements. The network was trained with variables obtained from a subgroup of 2544 patients with confirmed hepatitis C-virus (HCV) infections excluding variables directly linked to the diagnosis of HCV. All analyses were performed using the data mining solution "RayQ". Training results were visualized three-dimensionally and the distributions and characteristics of the clusters were explored within the map. RESULTS: All 2544 patients with confirmed chronic HCV diagnoses were localized in a clearly defined cluster within the Kohonen self-organizing map. An additional 2217 patients who had not been diagnosed with hepatitis C co-localized to the same cluster, indicating socio-medical similarities and a potentially elevated risk of infection. Several factors including, age, diagnosis codes and drug prescriptions acted only in conjunction as predictors of an elevated HCV risk. CONCLUSIONS: This ANN approach may allow for a more efficient risk adapted HCV-screening. However, further validation of the prediction model is required.
6
Scott D. Ramsey, Joseph M. Unger, Laurence H. Baker et al. · JAMA Oncology · 2019 · 90 citations · Full text
Medicine, Oncology, Cancer Control +10